Dr. Don Kenkel
Andrew Dickson White Professor
Jeb E. Brooks School of Public Policy at Cornell University

Donald Kenkel's expertise is in areas of health economics and public sector economics. Broadly speaking, most of his research is on the economics of disease prevention and health promotion. He is the author of the chapter on "Prevention" in the Handbook of Health Economics (2000). He has conducted a series of studies on the economics of public health policies, including: alcohol taxes and other policies to prevent alcohol problems (Journal of Applied Econometrics 2001, American Economic Review Papers & Proceedings 2005); cigarette taxes to prevent youth smoking (Journal of Political Economy 2002, Journal of Health Economics 2008); and advertising to promote smoking cessation (Journal of Political Economy 2007). His current research is on the economics of cigarette sales on Indian reservations (National Tax Journal 2015), the economics of tobacco regulation (Journal of Benefit-Cost Analysis 2015), and the market for e-cigarettes (Journal of Health Economics 2019).

Sessions with Dr. Don Kenkel

Panel
VA, United States, 22202
15:45 - 16:45
In an effort to enhance transparency, FDA released a series of regulatory science policy memoranda outlining its latest thinking on toxicology assessments, excess lifetime cancer risk (ELCR) calculations, and other critical scientific evaluations in tobacco product applications. These memos provide valuable insights into the FDA’s evolving approach to reviewing PMTAs, shaping testing methodologies, and setting new regulatory expectations. Hear experts discuss these memos, exploring their impact on risk assessments, study design, and the overall PMTA process.

Moderators

Speakers

  • Dr. Jenna Guynn

    Senior Director, Scientific and Regulatory Affairs, Reynolds American

  • Dr. Matthew Holman

    Vice President and Chief Scientific and Regulatory Strategy Officer for the US, PMI

  • Dr. Don Kenkel

    Andrew Dickson White Professor, Jeb E. Brooks School of Public Policy at Cornell University

  • Dr. Charlene Liu

    President and Chief Scientist, Riskwise Solution